.-In 3T3-L1 adipocytes, insulin activates three major signaling cascades, the phosphoinositide 3-kinase (PI3K) pathway, the Cbl pathway, and the mitogen-activated protein kinase (MAPK) pathway. Although PI3K and Cbl mediate insulin-stimulated glucose uptake by promoting the translocation of the insulin-responsive glucose transporter (GLUT4) to the plasma membrane, the MAPK pathway does not have an established role in insulin-stimulated glucose uptake. We demonstrate in this report that PI3K inhibitors also inhibit the MAPK pathway. To investigate the role of the MAPK pathway separately from that of the PI3K pathway in insulin-stimulated glucose uptake, we used two specific inhibitors of MAPK kinase (MEK) activity, PD-98059 and U-0126, which reduced insulin-stimulated glucose uptake by ϳ33 and 50%, respectively. Neither MEK inhibitor affected the activation of Akt or PKC/, downstream signaling molecules in the PI3K pathway. Inhibition of MEK with U-0126 did not prevent GLUT4 from translocating to the plasma membrane, nor did it inhibit the subsequent docking and fusion of GLUT4-myc with the plasma membrane. MEK inhibitors affected glucose transport mediated by GLUT4 but not GLUT1. Importantly, the presence of MEK inhibitors only at the time of the transport assay markedly impaired both insulin-stimulated glucose uptake and MAPK signaling. Conversely, removal of MEK inhibitors before the transport assay restored glucose uptake and MAPK signaling. Collectively, our studies suggest a possible role for MEK in the activation of GLUT4. p44/p42 mitogen-activated protein kinase; glucose transporter 4; glucose transport; U-0126; PD-98059 THE BINDING OF INSULIN to its receptor triggers multiple signaling pathways that participate broadly in cellular growth and differentiation and in the metabolism of lipids and glucose. To maintain glucose homeostasis, insulin not only inhibits the production of glucose in the liver but also stimulates the transport of glucose into muscle and adipose tissue for subsequent use or storage. Autophosphorylation of the insulin receptor tyrosine kinase results in the recruitment and tyrosine phosphorylation of substrates and the activation of three major pathways, the phosphoinositide 3-kinase (PI3K) pathway, the mitogen-activated protein kinase (MAPK) pathway, and the Cbl pathway (see review in Ref.3). PI3K catalyzes the formation of phosphatidylinositol-3,4,5-trisphosphate, or PIP 3 , an allosteric activator of phosphoinositide-dependent kinase (PDK). Targets of PDK include Akt and the atypical PKC isoforms, which, when activated via phosphorylation, stimulate the translocation of the insulin-responsive glucose transporter (GLUT4)-containing vesicles to the plasma membrane. Phospholipase C-␥1 (PLC-␥1), another downstream target of PI3K in insulin signaling, also facilitates GLUT4 translocation (13,25). Although the relative contributions of PLC-␥1, Akt, and atypical PKCs to GLUT4 translocation remain controversial, studies have demonstrated the necessity of PI3K activity for insulin-stimulated...